Listed

Cumberland Pharmaceuticals Inc: Form 10-K for the period ended Dec 31, 2011

Filed with the SEC on Mar 7, 2012 and accepted by EDGAR at Mar 7, 2012, 17:29 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2011-01-01 to 2011-12-31$51.1mus-gaap:SalesRevenueNet
Cost of revenue12 months2011-01-01 to 2011-12-31$5.4mus-gaap:CostOfGoodsSold
Research and development12 months2011-01-01 to 2011-12-31$5.0mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2011-01-01 to 2011-12-31$9.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2011-01-01 to 2011-12-31$353.5kus-gaap:InterestExpense
Income tax12 months2011-01-01 to 2011-12-31$4.1mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2011-01-01 to 2011-12-31$5.7mus-gaap:NetIncomeLoss
Diluted EPS12 months2011-01-01 to 2011-12-31$0.28us-gaap:EarningsPerShareDiluted
Basic EPS12 months2011-01-01 to 2011-12-31$0.28us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2011-01-01 to 2011-12-3120,572,132 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2011-01-01 to 2011-12-31$8.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-01-01 to 2011-12-31$257.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2011-01-01 to 2011-12-31$4.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2011-12-31$70.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-12-31$87.3mus-gaap:AssetsCurrent
Total assetsAt period end2011-12-31$95.5mus-gaap:Assets
Current liabilitiesAt period end2011-12-31$6.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-12-31$12.7mus-gaap:Liabilities
Current portion of debtAt period end2011-12-31$0us-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2011-12-31$82.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-12-101478. Last ingested by Listed: Nov 14, 2026, 23:39 ET. Listed shows no prices and gives no investment advice.